Camson Bio Technologies inks MOU with Wageningen University, Netherlands

05 Aug 2011 Evaluate

Camson Bio Technologies has inked an memorandum of understanding (MOU) with Wageningen University, Netherlands, to jointly develop cysgenisis in horticulture crops for qualitative and quantitative improvement. Cysgenisis is known as safe GMO. This arrangement is an exclusive one between Camson and Wageningen University, Netherlands and together they will work to transfer the construct in the selective Indian cultivars / Hybrids developed by Camson.

This is a path breaking collaboration which will help in removing the fear of transgenic from the minds of consumer. Camson is looking forward to a great opportunity in the field where none are present at the moment.

Recently, Camson Bio Technologies had filed four applications on June 14, 2011, under the different categories of bio-pesticidal and bio-weedicidal formulation and a process of preparation thereof with the controller of patents and design.

Camson Bio Technologies operates as an integrated agriculture biotechnology company in India. It produces hybrid seeds, bio-fungicides, bio-insecticides, bio-stimulants, bio-fertilizers, and biocides catering to the requirements of farmers.

Camson Bio Share Price

3.31 0.00 (0.00%)
11-May-2020 18:01 View Price Chart
Peers
Company Name CMP
Venkys India 1466.25
Mangalam Global Ent 14.32
Kaveri Seed 966.25
Regaal Resources 68.10
Simran Farms 172.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×